{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:32Z","timestamp":1792528772540,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Clozapine is the most effective antipsychotic drug, while also causing the most severe metabolic side effects. The underlying mechanisms of these side effects appear multifactorial and are not entirely understood. We hypothesized that liver sinusoidal endothelial cells (LSEC) dysfunction is linked to the metabolic side effects of clozapine, based on known association between reduced LSEC porosity, hypertriglyceridemia and insulin resistance. Accordingly, we conducted a translational study by assessing the porosity of murine LSECs following clozapine exposure in vitro and correlating serum clozapine concentrations with metabolic parameters in routine human blood samples. The patient data showed a correlation for clozapine serum concentrations with both triglycerides (Spearman\u2019s \u03c1\u2009=\u20090.47,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.00024) and glucose levels (\u03c1\u2009=\u20090.24,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.034), but no correlation with LDL cholesterol (\u03c1\u2009=\u2009\u22120.04,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.82) or HDL cholesterol (\u03c1\u2009=\u2009\u22120.22,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.088). The in vitro experiments showed a concentration-dependent reduction in murine LSEC porosity (P for trend = 0.00036). Together, these findings support a link between clozapine exposure and reduced LSEC porosity. This represents a promising point of intervention that potentially could expand safe access to clozapine as a highly effective antipsychotic treatment for a broader population, also in individuals at high risk for metabolic and cardiovascular side effects.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04328-4","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:44:51Z","timestamp":1786009491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between clozapine-induced hypertriglyceridemia and defenestration of liver sinusoidal endothelial cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Tetyana","family":"Voloshyna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-6904","authenticated-orcid":false,"given":"\u00d8yvind V.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Szafranska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Posp\u00ed\u0161il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike C.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"St\u00f8rset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Le Couteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Cogger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-4590","authenticated-orcid":false,"given":"Peter A. G.","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5679-9937","authenticated-orcid":false,"given":"Erik S.","family":"Dietrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"4328_CR1","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019. Mol Psychiatry. 2023;28:5319\u201327.","journal-title":"Mol Psychiatry"},{"key":"4328_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/j.2051-5545.2009.tb00199.x","volume":"8","author":"M De Hert","year":"2009","unstructured":"De Hert M, Schreur V, Vancampfort D, van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009;8:15\u201322.","journal-title":"World Psychiatry"},{"key":"4328_CR3","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"4328_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7:64\u201377.","journal-title":"Lancet Psychiatry"},{"key":"4328_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. \u2018Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls\u2019. World Psychiatry. 2017;16:163\u201380.","journal-title":"World Psychiatry"},{"key":"4328_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.schres.2005.12.855","volume":"83","author":"MA De Hert","year":"2006","unstructured":"De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr Res. 2006;83:87\u201393.","journal-title":"Schizophr Res"},{"key":"4328_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorth\u00f8j","year":"2017","unstructured":"Hjorth\u00f8j C, St\u00fcrup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295\u2013301.","journal-title":"Lancet Psychiatry"},{"key":"4328_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1177-y","volume":"17","author":"AL Gillespie","year":"2017","unstructured":"Gillespie AL, Samanaite R, Mill J, Egerton A, MacCabe JH. Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review. BMC Psychiatry. 2017;17:12.","journal-title":"BMC Psychiatry"},{"key":"4328_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/biomedicines11041072","volume":"11","author":"V Peitl","year":"2023","unstructured":"Peitl V, Pulji\u0107 A, \u0160krobo M, Nadalin S, Fumi\u0107 Dunki\u0107 L, Karlovi\u0107 D. Clozapine in treatment-resistant schizophrenia and its augmentation with electroconvulsive therapy in ultra-treatment-resistant schizophrenia. Biomedicines. 2023;11:1072.","journal-title":"Biomedicines"},{"key":"4328_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. The Lancet. 2019;394:939\u201351.","journal-title":"The Lancet"},{"key":"4328_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01613-2","volume":"11","author":"E Wagner","year":"2021","unstructured":"Wagner E, Siafis S, Fernando P, Falkai P, Honer WG, R\u00f6h A, et al. Efficacy and safety of clozapine in psychotic disorders\u2014a systematic quantitative meta-review. Transl Psychiatry. 2021;11:487.","journal-title":"Transl Psychiatry"},{"key":"4328_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/acps.13406","volume":"145","author":"RJ Gurrera","year":"2022","unstructured":"Gurrera RJ, Gearin PF, Love J, Li KJ, Xu A, Donaghey FH, et al. Recognition and management of clozapine adverse effects: A systematic review and qualitative synthesis. Acta Psychiatr Scand. 2022;145:423\u201341.","journal-title":"Acta Psychiatr Scand"},{"key":"4328_CR13","doi-asserted-by":"publisher","unstructured":"Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM A focused review of the metabolic side-effects of clozapine. Front Endocrinol 2021;12. https:\/\/doi.org\/10.3389\/fendo.2021.609240.","DOI":"10.3389\/fendo.2021.609240"},{"key":"4328_CR14","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/ijms18102174","volume":"18","author":"SW Jeon","year":"2017","unstructured":"Jeon SW, Kim Y-K. Unresolved issues for utilization of atypical antipsychotics in schizophrenia: antipsychotic polypharmacy and metabolic syndrome. Int J Mol Sci. 2017;18:2174.","journal-title":"Int J Mol Sci"},{"key":"4328_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S2215-0366(25)00129-4","volume":"12","author":"D Siskind","year":"2025","unstructured":"Siskind D, Baker A, Arnautovska U, Warren N, Russell A, DeMonte V, et al. Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia. Lancet Psychiatry. 2025;12:493\u2013503.","journal-title":"Lancet Psychiatry"},{"key":"4328_CR16","first-page":"863","volume":"21","author":"R Fraser","year":"1995","unstructured":"Fraser R, Dobbs BR, Rogers GWT. Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology. 1995;21:863\u201374.","journal-title":"Hepatology"},{"key":"4328_CR17","doi-asserted-by":"publisher","unstructured":"Szafranska K, Kruse LD, Holte CF, McCourt P, Zapotoczny B The wHole story about fenestrations in LSEC. Front Physiol 2021; 12. https:\/\/doi.org\/10.3389\/fphys.2021.735573.","DOI":"10.3389\/fphys.2021.735573"},{"key":"4328_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/ar.20661","volume":"291","author":"DG Le Couteur","year":"2008","unstructured":"Le Couteur DG, Warren A, Cogger VC, Smedsr\u00f8d B, S\u00f8rensen KK, De Cabo R, et al. Old age and the hepatic sinusoid. Anat Rec. 2008;291:672\u201383.","journal-title":"Anat Rec"},{"key":"4328_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","volume":"66","author":"J Poisson","year":"2017","unstructured":"Poisson J, Lemoinne S, Boulanger C, Durand F, Moreau R, Valla D, et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2017;66:212\u201327.","journal-title":"J Hepatol"},{"key":"4328_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hep.20937","volume":"42","author":"SN Hilmer","year":"2005","unstructured":"Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology. 2005;42:1349\u201354.","journal-title":"Hepatology"},{"key":"4328_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/acel.12481","volume":"15","author":"M Mohamad","year":"2016","unstructured":"Mohamad M, Mitchell SJ, Wu LE, White MY, Cordwell SJ, Mach J, et al. Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age-related insulin resistance. Aging Cell. 2016;15:706\u201315.","journal-title":"Aging Cell"},{"key":"4328_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1124\/dmd.119.086496","volume":"47","author":"A Parkinson","year":"2019","unstructured":"Parkinson A. Regulatory recommendations for calculating the unbound maximum hepatic inlet concentration: a complicated story with a surprising and happy ending. Drug Metab Dispos. 2019;47:779\u201384.","journal-title":"Drug Metab Dispos"},{"key":"4328_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2125.1998.00822.x","volume":"46","author":"G Schaber","year":"1998","unstructured":"Schaber G, Stevens I, Gaertner HJ, Dietz K, Breyer-Pfaff U. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance. Br J Clin Pharmacol. 1998;46:453\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"4328_CR24","unstructured":"The European Agency for the Evaluation of Medicinal Products. Summary information on referral opinion following arbitration pursuant to Article 30 of Council Directive 2001\/83\/EC for Leponex and associated names (INN: clozapine). European Medicines Agency, 2002. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/summary-information-referral-opinion-following-arbitration-pursuant-article-30-council-directive-200183ec-leponex-and-associated-names-international-non-proprietary-name-inn-clozapine-background_en.pdf."},{"key":"4328_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-2125.1997.t01-1-00606.x","volume":"44","author":"M Jerling","year":"1997","unstructured":"Jerling M, Merl\u00e9 Y, Mentr\u00e9 F, Mallet A. Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method. Br J Clin Pharmacol. 1997;44:447\u201353.","journal-title":"Br J Clin Pharmacol"},{"key":"4328_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1124\/dmd.106.013359","volume":"35","author":"J Yang","year":"2007","unstructured":"Yang J, Jamei M, Yeo KR, Rostami-Hodjegan A, Tucker GT. Misuse of the well-stirred model of hepatic drug clearance. Drug Metab Dispos. 2007;35:501\u20132.","journal-title":"Drug Metab Dispos"},{"key":"4328_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2125.2003.01821.x","volume":"56","author":"R Flanagan","year":"2003","unstructured":"Flanagan R, Yusufi B, Barnes T. Comparability of whole-blood and plasma clozapine and norclozapine concentrations. Br J Clin Pharmacol. 2003;56:135\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"4328_CR28","doi-asserted-by":"crossref","unstructured":"Elvevold K, Kyrrestad I, Smedsr\u00f8d B Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution. In: Arechavala-Gomeza V, Garanto A (eds). Antisense RNA Design, Delivery, and Analysis. New York, NY: Springer US, 2022, pp 385\u2013402.","DOI":"10.1007\/978-1-0716-2010-6_27"},{"key":"4328_CR29","doi-asserted-by":"crossref","unstructured":"Weigert M, Schmidt U Nuclei Instance Segmentation and Classification in Histopathology Images with Stardist. In: 2022 IEEE International Symposium on Biomedical Imaging Challenges (ISBIC). 2022, pp 1\u20134.","DOI":"10.1109\/ISBIC56247.2022.9854534"},{"key":"4328_CR30","doi-asserted-by":"crossref","unstructured":"Schmidt U, Weigert M, Broaddus C, Myers G Cell Detection with Star-Convex Polygons. In: Frangi AF, Schnabel JA, Davatzikos C, Alberola-L\u00f3pez C, Fichtinger G (eds). Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2018. Cham: Springer International Publishing, 2018, pp 265-73.","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"4328_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40227-0","volume":"13","author":"H Mao","year":"2023","unstructured":"Mao H, Szafranska K, Kruse L, Holte C, Wolfson DL, Ahluwalia BS, et al. Effect of caffeine and other xanthines on liver sinusoidal endothelial cell ultrastructure. Sci Rep. 2023;13:13390.","journal-title":"Sci Rep"},{"key":"4328_CR32","doi-asserted-by":"publisher","first-page":"e0617","DOI":"10.1097\/HC9.0000000000000617","volume":"9","author":"LD Kruse","year":"2025","unstructured":"Kruse LD, Holte C, Zapotoczny B, Struck EC, Sch\u00fcrstedt J, H\u00fcbner W, et al. Hydrogen peroxide damage to rat liver sinusoidal endothelial cells is prevented by n-acetyl-cysteine but not GSH. Hepatol Commun. 2025;9:e0617.","journal-title":"Hepatol Commun"},{"key":"4328_CR33","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/sim.1545","volume":"22","author":"VMR Muggeo","year":"2003","unstructured":"Muggeo VMR. Estimating regression models with unknown break-points. Stat Med. 2003;22:3055\u201371.","journal-title":"Stat Med"},{"key":"4328_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00213-020-05746-y","volume":"238","author":"MSA Tan","year":"2021","unstructured":"Tan MSA, Honarparvar F, Falconer JR, Parekh HS, Pandey P, Siskind DJ. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions. Psychopharmacology (Berl). 2021;238:615\u201337.","journal-title":"Psychopharmacology (Berl)"},{"key":"4328_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/ph15070817","volume":"15","author":"M Skokou","year":"2022","unstructured":"Skokou M, Karavia EA, Drakou Z, Konstantinopoulou V, Kavakioti C-A, Gourzis P, et al. Adverse drug reactions in relation to clozapine plasma levels: a systematic review. Pharmaceuticals. 2022;15:817.","journal-title":"Pharmaceuticals"},{"key":"4328_CR36","unstructured":"De Zanger R, Wisse E The filtration effect of rat liver fenestrated sinusoidal endothelium on the passage of (remnant) chylomicrons to the space of Disse. In: Knook DL, Wisse E, editors. Sinusoidal Liver Cells. Elsevier; 1982. pp. 69\u201376."},{"key":"4328_CR37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, Viscarra J, Kim S-J, Sul HS. Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015;16:678\u201389.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4328_CR38","doi-asserted-by":"crossref","unstructured":"Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. The Lancet. 2002;359:1612\u20135.","DOI":"10.1016\/S0140-6736(02)08524-0"},{"key":"4328_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/clinchem\/hvaa296","volume":"67","author":"EK Duran","year":"2021","unstructured":"Duran EK, Pradhan AD. Triglyceride-Rich lipoprotein remnants and cardiovascular disease. Clin Chem. 2021;67:183\u201396.","journal-title":"Clin Chem"},{"key":"4328_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1s\u0306ov\u00e1","year":"2001","unstructured":"Dobi\u00e1s\u0306ov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34:583\u20138.","journal-title":"Clin Biochem"},{"key":"4328_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/diagnostics13050929","volume":"13","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Pe\u00f1a Genao E, Guzman E, et al. The triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics. 2023;13:929.","journal-title":"Diagnostics"},{"key":"4328_CR42","first-page":"278","volume":"75","author":"NJ Hunt","year":"2020","unstructured":"Hunt NJ, Lockwood GP, Kang SW, Pulpitel T, Clark X, Mao H, et al. The effects of metformin on age-related changes in the liver sinusoidal endothelial cell. J Gerontol Ser A. 2020;75:278\u201385.","journal-title":"J Gerontol Ser A"},{"key":"4328_CR43","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/hep.30232","volume":"69","author":"B Zapotoczny","year":"2019","unstructured":"Zapotoczny B, Szafranska K, Kus E, Braet F, Wisse E, Chlopicki S, et al. Tracking fenestrae dynamics in live murine liver sinusoidal endothelial cells. Hepatology. 2019;69:876\u201388.","journal-title":"Hepatology"},{"key":"4328_CR44","doi-asserted-by":"publisher","first-page":"G144","DOI":"10.1152\/ajpgi.00179.2018","volume":"316","author":"NJ Hunt","year":"2019","unstructured":"Hunt NJ, Lockwood GP, Warren A, Mao H, McCourt PAG, Le Couteur DG, et al. Manipulating fenestrations in young and old liver sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol. 2019;316:G144\u2013G154.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4328_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","volume":"142","author":"G Xie","year":"2012","unstructured":"Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology. 2012;142:918\u2013927.e6.","journal-title":"Gastroenterology"},{"key":"4328_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7150\/ntno.103000","volume":"9","author":"T Voloshyna","year":"2025","unstructured":"Voloshyna T, Holte C, Posp\u00ed\u0161il J, Szafranska K, Fuskev\u00e5g OM, Strand SP, et al. PACA nanoparticles target and deliver sildenafil to rejuvenate aged mouse liver sinusoidal endothelial cells. Nanotheranostics. 2025;9:155\u201370.","journal-title":"Nanotheranostics"},{"key":"4328_CR47","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 2010;9:929\u201339.","journal-title":"Nat Rev Drug Discov"},{"key":"4328_CR48","doi-asserted-by":"crossref","unstructured":"H\u00f6ck E, Buchholz T-O, Brachmann A, Jug F, Freytag A N2V2 - Fixing Noise2Void Checkerboard Artifacts with Modified Sampling Strategies and a Tweaked Network Architecture. In: Karlinsky L, Michaeli T, Nishino K (eds). Computer Vision \u2013 ECCV 2022 Workshops. Cham: Springer Nature Switzerland, 2023, pp 503-18.","DOI":"10.1007\/978-3-031-25069-9_33"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04328-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:02:47Z","timestamp":1792526567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04328-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4328"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04328-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EM has received speaker\u2019s honoraria from Otsuka and Lundbeck. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"577"}}